Abstract
Sotos syndrome is a complex genetic disease first
described by Sotos' in 1964. The four major criteria in the
diagnosis were established in 1994 by Cole and Hughes'.
Basing their findings on the systematic assessment of 41
typical cases they characterized this syndrome by:
1. Advanced bone age.
2. Macrocephaly.
3. Characteristic facial appearance: the face is
round with an abnormal prominence of the forehead and
becomes longer in adolescence.
4. Learning difficulties. This is often associated
with delay in walking that can start after 15 months of age
and speech delay until 2,5 year of age.
Other findings include dolicocephaly, prognatism,
hypertelorism, high-arched palate, early eruption of
teeth, seizures, scoliosis and congenital heart defects 3-4.
Affected patients also show social contact problems and
anxious behavior 5. For forty years the diagnosis of Sotos
syndrome has been based on subjective evaluation of
clinical features. More recently genetic studies showed
mutations of gene NSD 1 in almost all the patients. The
intragenic mutation of NSD 1 gene causes 60-80% of
Sotos syndromes in Europe and USA, whereas 5q35
microdelections encompassing NSD 1 cause 10% of cases
6-7. In contrast, NSDI microdelections are the primary
cause ofSotos syndrome in Japan where the incidence the
incidence of congenital heart defects seems to be higher
8. The gene NSDI encodes a hystone methyltransferase
implicated in chromatin regulation 9.
We present a case ofSotos syndrome which underwent
regional anesthesia with spontaneous breath sedation for
neurological flat foot.
Original language | English |
---|---|
Pages (from-to) | 21 (S2)-23 (S2) |
Number of pages | 3 |
Journal | International Journal of Immunopathology and Pharmacology |
Volume | 2011 vol. 1 |
Publication status | Published - 2011 |
Keywords
- Airway Management
- Anesthesia, Conduction
- Anesthesia, Inhalation
- Child
- Foot Diseases
- Humans
- Male
- Methyl Ethers
- Nerve Block
- Nervous System Diseases
- Sciatic Nerve
- Sotos Syndrome